Invesco
BBNX

Invesco’s Beta Bionics BBNX Stock Holding History

Invesco’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
21,021
+1,557
+8% +$18.5K ﹤0.01% 3404
2026
Q1 		$195K Sell
19,464
-97,896
-83% -$1.45M ﹤0.01% 3487
2025
Q4 		$3.58M Buy
117,360
+68,640
+141% +$1.83M ﹤0.01% 2392
2025
Q3 		$968K Buy
48,720
+32,424
+199% +$570K ﹤0.01% 2948
2025
Q2 		$237K Sell
16,296
-168
-1% -$2.38K ﹤0.01% 3466
2025
Q1 		$202K Buy
+16,464
New +$307K ﹤0.01% 3509

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Invesco's BBNX Position: Q2 2026 in Review

Invesco increased its Beta Bionics (BBNX) stake by 8% in Q2 2026, buying an estimated $18.5K and bringing the position to 21,021 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #3404.

Invesco first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.58M in Q4 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Invesco held 21,021 shares of Beta Bionics worth $329K as of Q2 2026.
  • Invesco bought 1,557 Beta Bionics shares in Q2 2026, an estimated $18.5K.
  • Beta Bionics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3404 holding.
  • Invesco first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Invesco's Beta Bionics position peaked at $3.58M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.